相关实验视频
Updated: Mar 3, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
16.7K
药物聚合物纳米颗粒:生物医学解决方案和向药物输送的进步
Pranita Rananaware1, Mahesh Narayan2, Varsha Brahmkhatri1,3
1Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bengaluru, Karnataka, India.
Drug design, development and therapy
|March 2, 2026
概括
聚合物纳米粒子 (PNPs) 通过改善药理动力学和降低毒性来提供多功能药物输送. 这些可适应的平台增强了治疗各种疾病的疗效,包括癌症和神经退行性疾病.
科学领域:
- 生物医学研究的研究.
- 纳米技术纳米技术
- 聚合物化学 聚合物化学
背景情况:
- 聚合物纳米粒子 (PNPs) 是多功能生物医学平台 (10-1000 nm).
- 它们具有可调整的大小,表面功能,高药载荷和生物相容性.
- PNP有效地封装,保护和提供各种治疗剂.
研究的目的:
- 审查聚合物纳米颗粒在现代生物医学研究中的作用和应用.
- 突出PNP提高药物输送和治疗结果的能力.
- 讨论制造技术和纳米材料整合的影响.
主要方法:
- 复习现有的关于聚合物纳米粒子制造和应用的文献.
- 对影响PNP性能的物理化学性质的分析.
- 探索PNP与向配体和各种纳米材料的集成.
主要成果:
- PNP可以改善药物的药理动力学和药理动力学特征.
- 它们增强溶解度,控制释放,并减少全身毒性.
- 向配体和纳米材料集成扩大了治疗潜力.
结论:
- 聚合物纳米粒子是下一代治疗方法的适应性和强大的工具.
- 它们的生物相容性和设计灵活性使其在治疗复杂疾病方面具有广泛的应用.
- PNPs显著影响药物行为,提供增强的疗效和降低毒性.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Modified-Release Drug Delivery Systems: Classification
105
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
105
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
281
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
281
Oral Drug Delivery Systems: Introduction
85
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
85

